Profil
Ron Ellis is currently a Director at GeneQuine Biotherapeutics GmbH and CarthroniX, Inc. He was formerly a Chief Strategy Officer at Pacira Biosciences, Inc. Dr. Ellis holds an MBA from St. Joseph's University and a doctorate from Philadelphia College of Osteopathic Medicine.
Postes actifs de Ron Ellis
| Sociétés | Poste | Début |
|---|---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration | Directeur/Membre du Conseil | - |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services Provides wound healing, small molecule based therapy skin regeneration, and novel solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Ron Ellis
| Sociétés | Poste | Fin |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formation de Ron Ellis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philadelphia College of Osteopathic Medicine
Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration | Health Technology |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services Provides wound healing, small molecule based therapy skin regeneration, and novel solutions | Health Services |
















